Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Assets (2016 - 2021)

Historic Assets for Neurocrine Biosciences (NBIX) over the last 12 years, with Q3 2021 value amounting to $2.0 billion.

  • Neurocrine Biosciences' Assets rose 3425.4% to $2.0 billion in Q3 2021 from the same period last year, while for Sep 2021 it was $2.0 billion, marking a year-over-year increase of 3425.4%. This contributed to the annual value of $1.7 billion for FY2020, which is 3282.54% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Assets stood at $2.0 billion for Q3 2021, which was up 3425.4% from $2.0 billion recorded in Q2 2021.
  • Over the past 5 years, Neurocrine Biosciences' Assets peaked at $2.0 billion during Q3 2021, and registered a low of $289.4 million during Q1 2017.
  • For the 5-year period, Neurocrine Biosciences' Assets averaged around $1.2 billion, with its median value being $1.1 billion (2019).
  • In the last 5 years, Neurocrine Biosciences' Assets plummeted by 3700.33% in 2017 and then skyrocketed by 17866.63% in 2018.
  • Over the past 5 years, Neurocrine Biosciences' Assets (Quarter) stood at $817.6 million in 2017, then grew by 21.47% to $993.2 million in 2018, then surged by 31.5% to $1.3 billion in 2019, then skyrocketed by 32.83% to $1.7 billion in 2020, then grew by 16.29% to $2.0 billion in 2021.
  • Its Assets stands at $2.0 billion for Q3 2021, versus $2.0 billion for Q2 2021 and $1.8 billion for Q1 2021.